Post by Nykode Therapeutics

Resharing this new episode of the RADFORSK podcast featuring Nykode Therapeutics’ Michael Engsig and Agnete Fredriksen reflection on where Nykode stands today. In this conversation they cover: ·      Our recently strengthened board, welcoming Dr. Barbara Krebs-Pohl and Dr. John Beadle ·      Our progress on the Abili-T trial ·      Our latest data from VB-C-03 trial ·      Our work on the tolerance platform for autoimmune diseases ·      How Nykode applies AI to advance immunotherapies It's been a year of real momentum, and we're excited about what comes next. (Podcast and original post in Norwegian). #Immunotherapy #Biotech #Nykode #Autoimmune #AIinHealthcare #DrugDevelopment #Radiumpodcast https://lnkd.in/eBNkHSgT